One hypothesis of how this E-cadherin driven resistance mechanism may act, is that E-cadherin is shed from the tumor cells in a soluble form, which – as shown in in vitro model systems [22] – may then activate EGFR promoting cell survival [62]. The gene discussed is EGFR; the disease is neoplasm.